keyword
https://read.qxmd.com/read/37101395/circular-mthfd2l-rna-encoded-cm-248aa-inhibits-gastric-cancer-progression-by-targeting-the-set-pp2a-interaction
#1
JOURNAL ARTICLE
Haohan Liu, Deliang Fang, Chaoyue Zhang, Zirui Zhao, Yinan Liu, Shaoji Zhao, Nu Zhang, Jianbo Xu
The available targeted therapies for gastric cancer (GC) are still limited, so it is significant to discover novel molecules as potential treatment options. Proteins or peptides encoded by circular RNAs (circRNAs) are increasingly reported to play essential roles in malignancies. The aim of the present study was to identify an undiscovered protein encoded by circRNA and explore its key role and molecular mechanism in GC progression. CircMTHFD2L (hsa_circ_0069982) was screened and validated as a downregulated circRNA with coding potential...
April 26, 2023: Molecular Therapy
https://read.qxmd.com/read/28938158/directional-migration-in-esophageal-squamous-cell-carcinoma-escc-is-epigenetically-regulated-by-set-nuclear-oncogene-a-member-of-the-inhibitor-of-histone-acetyltransferase-complex
#2
JOURNAL ARTICLE
Xiang Yuan, Xinshuai Wang, Bianli Gu, Yingjian Ma, Yiwen Liu, Man Sun, Jinyu Kong, Wei Sun, Huizhi Wang, Fuyou Zhou, Shegan Gao
Directional cell migration is of fundamental importance to a variety of biological events, including metastasis of malignant cells. Herein, we specifically investigated SET oncoprotein, a subunit of the recently identified inhibitor of acetyltransferases (INHAT) complex and identified its role in the establishment of front-rear cell polarity and directional migration in Esophageal Squamous Cell Carcinoma (ESCC). We further define the molecular circuits that govern these processes by showing that SET modulated DOCK7/RAC1 and cofilin signaling events...
November 2017: Neoplasia: An International Journal for Oncology Research
https://read.qxmd.com/read/25873066/tissue-proteomics-of-splenic-marginal-zone-lymphoma
#3
JOURNAL ARTICLE
Rita Polati, Jessica Brandi, Irene Dalai, Alberto Zamò, Daniela Cecconi
Splenic marginal zone lymphoma (SMZL) is a rare chronic B lymphoproliferative disease, whose molecular pathogenesis has still not been well established. For the first time, a proteomic approach was undertaken to analyse the protein profiles of SMZL tissue. 1D and 2D Western blot, immunohistochemical analysis, and functional data mining were also performed in order to validate results, investigate protein species specific regulation, classify proteins, and explore their potential relationships. We demonstrated that SMZL is characterized by modulation of protein species related to energetic metabolism and apoptosis pathways...
July 2015: Electrophoresis
https://read.qxmd.com/read/24932313/fbxl20-acts-as-an-invasion-inducer-and-mediates-e-cadherin-in-colorectal-adenocarcinoma
#4
JOURNAL ARTICLE
Jianjun Zhu, Shishan Deng, Jie Duan, Xingguo Xie, Shiquan Xu, Maocheng Ran, Xiaosi Dai, Yu Pu, Xiaoming Zhang
The mechanisms eliciting colorectal adenocarcinoma are not well understood and the FBXL20 gene is problematic as it exhibits an abnormal expression in colorectal cancer cells. In the present study a recombinant plasmid, pReceiver-M03-FBL20 expression plasmid was constructed, which overexpressed FBXL20; this was transfected into Lovo cells to form Lovo-FBL20 cells. The FBXL20 expression level was examined by quantitative polymerase chain reaction (qPCR) and western blot analysis. The cell viability and invasion capacity were measured using cell counting kit 8, Transwell chamber and wound healing assays, respectively...
June 2014: Oncology Letters
https://read.qxmd.com/read/24292090/proteomic-analysis-of-the-proteins-that-are-associated-with-the-resistance-to-paclitaxel-in-human-breast-cancer-cells
#5
JOURNAL ARTICLE
Siying Chen, Qian Dong, Sasa Hu, Jiangxia Cai, Weipeng Zhang, Jinyao Sun, Taotao Wang, Jiao Xie, Hairong He, Jianfeng Xing, Jun Lu, Yalin Dong
Cancers frequently develop resistance to paclitaxel but the underlying molecular mechanisms remain to be determined. We have investigated the proteins that are associated with the paclitaxel resistance in human breast cancer MCF-7 cells using proteomic analysis. Paclitaxel resistant human breast cancer MCF-7 cells (MCF-7/P) were established by escalating the concentrations of paclitaxel to drug-sensitive MCF-7 cells (MCF-7/S). The global protein profiles of MCF-7/P and MCF-7/S were compared using two-dimensional gel electrophoresis (2-DE) and matrix-assisted laser desorption/ionization time of flight mass spectrometry (MALDI-TOF-MS)...
February 2014: Molecular BioSystems
https://read.qxmd.com/read/21515671/set-nuclear-oncogene-associates-with-microcephalin-mcph1-and-regulates-chromosome-condensation
#6
JOURNAL ARTICLE
Justin W Leung, Andrea Leitch, Jamie L Wood, Charles Shaw-Smith, Kay Metcalfe, Louise S Bicknell, Andrew P Jackson, Junjie Chen
Primary microcephaly is an autosomal recessive disorder characterized by marked reduction in human brain size. Microcephalin (MCPH1), one of the genes mutated in primary microcephaly, plays an important role in DNA damage checkpoint control and mitotic entry. Additionally, MCPH1 ensures the proper temporal activation of chromosome condensation during mitosis, by acting as a negative regulator of the condensin II complex. We previously found that deletion of the of the MCPH1 N terminus leads to the premature chromosome condensation (PCC) phenotype...
June 17, 2011: Journal of Biological Chemistry
1
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.